Prostate cancer-associated mutation in SPOP impairs its ability to target Cdc20 for poly-ubiquitination and degradation.

Prostate cancer-associated mutation in SPOP impairs its ability to target Cdc20 for poly-ubiquitination and degradation.
复制标题

DOI:
10.1016/j.canlet.2016.10.021
复制
发表时间:
2017-01-28
期刊:
影响因子:
9.7
通讯作者:
Zhang, Jinfang
Zhang, Jinfang
中科院分区:
医学1区
文献类型:
--
作者:
Wu, Fei;Dai, Bxiangpeng;Gan, Wenjian;Wan, Lixin;Li, Min;Mitsiades, Nicholas;Wei, Wenyi;Ding, Qiang;Zhang, Jinfang

文献摘要

参考文献

被引文献

相似文献

最近的研究表明,高达15%的前列腺癌患者会发生SPOP(斑点型POZ蛋白)突变。然而,SPOP在调节前列腺癌发生中的生理作用仍不清楚。在这里,我们确定了CDC20癌蛋白是SPOP的一种新的泛素底物。因此,MLN4924对基于cullin的E3连接酶的药理抑制可以稳定细胞内内源性Cdc20。此外,我们发现cullin 3,以及cullin 1,在较小的程度上,与Cdc20特异地相互作用。耗尽cullin 3,而不是cullin 1,可以通过延长cdc20的半衰期来上调cdc20的表达。此外,作为cullin 3家族E3连接酶的接头蛋白,SPOP能与CDc20特异地相互作用,并以降解依赖的方式促进CDc20的多泛素化和随后的降解。重要的是,前列腺癌来源的SPOP突变体未能与CDC20相互作用以促进其降解。结果,具有高表达CDC20的SPOP缺陷的前列腺癌细胞对一种药理的CDC20抑制剂产生了抗药性。因此,我们的结果揭示了SPOP在肿瘤发生中的新作用,部分是通过促进CDC20癌蛋白的降解来实现的。
Recent studies revealed that mutations in SPOP (Speckle-type POZ protein) occur in up to 15% of patients with prostate cancer. However, the physiological role of SPOP in regulating prostate tumorigenesis remains elusive. Here, we identified the Cdc20 oncoprotein as a novel ubiquitin substrate of SPOP. As such, pharmacological inhibition of Cullin-based E3 ligases by MLN4924 could stabilize endogenous Cdc20 in cells. Furthermore, we found that Cullin 3, and, to a less extent, Cullin 1, specifically interacted with Cdc20. Depletion of Cullin 3, but not Cullin 1, could upregulate the abudance of Cdc20 largely via prolonging Cdc20 half-life. Moreover, SPOP, the adaptor protein of Cullin 3 family E3 ligase, specifically interacted with Cdc20, and promoted the poly-ubiquitinaton and subsequent degradation of Cdc20 in a degron-dependent manner. Importantly, prostate cancer-derived SPOP mutants failed to interact with Cdc20 to promote its degradation. As a result, SPOP-deficient prostate cancer cells with elevated Cdc20 expression became resistant to a pharmacological Cdc20 inhibitor. Therefore, our results revealed a novel role of SPOP in tumorigenesis in part by promoting the degradation of the Cdc20 oncoprotein.
DOI: 10.1016/j.cell.2008.07.022
发表时间: 2008-09-19
期刊: CELL
影响因子: 64.5
作者:
Duda, David M.;Borg, Laura A.;Scott, Daniel C.;Hunt, Harold W.;Hammel, Michal;Schulman, Brenda A.
通讯作者: Schulman, Brenda A.
DOI: 10.1016/j.ccr.2010.10.028
发表时间: 2010-12-14
期刊: CANCER CELL
影响因子: 50.3
作者:
Manchado, Eusebio;Guillamot, Maria;Malumbres, Marcos
通讯作者: Malumbres, Marcos
DOI: 10.1016/j.molcel.2015.07.026
发表时间: 2015-09-17
期刊: Molecular cell
影响因子: 16
作者:
Gan W;Dai X;Lunardi A;Li Z;Inuzuka H;Liu P;Varmeh S;Zhang J;Cheng L;Sun Y;Asara JM;Beck AH;Huang J;Pandolfi PP;Wei W
通讯作者: Wei W
DOI: 10.1038/onc.2011.151
发表时间: 2011-10-20
期刊: ONCOGENE
影响因子: 8
作者:
Li, C.;Ao, J.;Fu, J.;Lee, D-F;Xu, J.;Lonard, D.;O'Malley, B. W.
通讯作者: O'Malley, B. W.
DOI: 10.1038/nature09744
发表时间: 2011-02-10
期刊: NATURE
影响因子: 64.8
作者:
Berger, Michael F.;Lawrence, Michael S.;Demichelis, Francesca;Drier, Yotam;Cibulskis, Kristian;Sivachenko, Andrey Y.;Sboner, Andrea;Esgueva, Raquel;Pflueger, Dorothee;Sougnez, Carrie;Onofrio, Robert;Carter, Scott L.;Park, Kyung;Habegger, Lukas;Ambrogio, Lauren;Fennell, Timothy;Parkin, Melissa;Saksena, Gordon;Voet, Douglas;Ramos, Alex H.;Pugh, Trevor J.;Wilkinson, Jane;Fisher, Sheila;Winckler, Wendy;Mahan, Scott;Ardlie, Kristin;Baldwin, Jennifer;Simons, Jonathan W.;Kitabayashi, Naoki;MacDonald, Theresa Y.;Kantoff, Philip W.;Chin, Lynda;Gabriel, Stacey B.;Gerstein, Mark B.;Golub, Todd R.;Meyerson, Matthew;Tewari, Ashutosh;Lander, Eric S.;Getz, Gad;Rubin, Mark A.;Garraway, Levi A.
通讯作者: Garraway, Levi A.